The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Pet Cancer Therapeutics Market From 2026 To 2030?

The pet cancer therapeutics market has witnessed rapid growth in its size over recent years. Its value is projected to climb from $0.43 billion in 2025 to $0.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. Historically, this expansion can be attributed to various factors, including the rising incidence of cancer in companion animals, the development of conventional chemotherapy protocols, an increase in veterinary hospital infrastructure, advancements in diagnostic imaging for pets, and the growth of the companion animal population.

The pet cancer therapeutics market size is anticipated to experience substantial expansion in the coming years, with projections indicating growth to $0.72 billion by 2030 at a compound annual growth rate (CAGR) of 11.0%. This projected growth throughout the forecast period can be attributed to advancements in immunotherapy and targeted therapy, the integration of artificial intelligence into diagnosis and treatment, the expansion of online and retail pharmacy channels, increasing awareness regarding early cancer detection, and rising investment in veterinary oncology research. Major trends expected during this period include the rising adoption of targeted therapies for pet cancer, an increasing use of immunotherapy in companion animals, the expansion of multi-modal cancer treatment protocols, a growing focus on early cancer detection in pets, and the integration of palliative care in pet oncology.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9984&type=smp

What Core Drivers Are Transforming The Pet Cancer Therapeutics Market?

The increasing prevalence of pet cancer is expected to propel the growth of the pet cancer therapeutics market going forward. Pet cancer refers to the development of abnormal and uncontrolled cell growth in the body of a domesticated animal, such as a dog or cat, leading to the formation of a tumor. The increased prevalence of pet cancer is mostly driven by exposure to environmental toxins and pollutants, whereas genetic and lifestyle factors, as a result demand for more advanced and effective cancer therapeutics for pets is expected to increase. Pet cancer therapeutics help pet cancer by targeting and destroying cancer cells or slowing tumor growth, which improves survival outcomes and reduces pain and discomfort in affected animals. For instance, in 2025, according to the American Veterinary Medical Association (AVMA), a US-based Veterinary Health Authority, approximately 1 in 4 dogs will develop cancer in their lifetime, and this risk grows to 1 in 2 for dogs aged over 10. Therefore, an increasing prevalence of pet cancer will fuel the pet cancer therapeutics market growth.

What Segment Types Are Included In The Pet Cancer Therapeutics Market Analysis?

The pet cancer therapeutics market covered in this report is segmented –

1) By Cancer Type: Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer

2) By Species: Dogs, Cats, Other Species

3) By Therapy: Chemotherapy, Radiation Therapy, Immunotherapy, Tomotherapy, Other Therapies

4) By End User: Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users

Subsegments:

1) By Melanoma: Surgical Interventions, Chemotherapy, Immunotherapy, Targeted Therapy

2) By Mast Cell Cancer: Surgery, Chemotherapy, Tyrosine Kinase Inhibitors, Radiation Therapy

3) By Lymphoma: Chemotherapy Protocols, Steroid Therapy, Radiation Therapy, Immunotherapy

4) By Mammary And Squamous Cell Cancer: Surgical Treatment, Chemotherapy, Radiation Therapy, Palliative Care Options

Which Trends Are Expected To Shape The Pet Cancer Therapeutics Market?

Major companies operating in the pet cancer therapeutics market are developing technologies such as epigenetic technology to enhance treatment efficacy and precision in targeting cancer cells, ultimately improving outcomes for pets affected by cancer. Epigenetic technology refers to methods that modify gene expression without changing the underlying DNA sequence, often influencing cellular behavior and potential therapeutic outcomes. For instance, in April 2024, VolitionRx Limited, a US-based multi-national epigenetics company, launched the Nu.Q Vet Cancer Test. The Nu.Q Vet Cancer Test operates on the Element i+ Analyzer, allowing for quick results, typically within about 6 minutes. It utilizes an enzyme-linked immunosorbent assay to detect circulating nucleosomes in the blood, which can indicate the presence of cancer.

Which Organizations Are Operating Within The Pet Cancer Therapeutics Market?

North America was the largest region in the pet cancer therapeutics market in 2025. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Pet Cancer Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/pet-cancer-therapeutics-global-market-report

Which Area Represents The Largest Portion Of The Pet Cancer Therapeutics Market?

North America was the largest region in the pet cancer therapeutics market in 2025. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Pet Cancer Therapeutics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9984&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model